Cargando…

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study

BACKGROUND: Primaquine is the only licensed drug for eradicating Plasmodium vivax hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of global malaria elimination efforts. Primaquine is efficacious when supervised in clinical trials, but its effectiveness in re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Nicholas M., Poespoprodjo, Jeanne Rini, Patriani, Dewi, Malloy, Michael J., Kenangalem, Enny, Sugiarto, Paulus, Simpson, Julie A., Soenarto, Yati, Anstey, Nicholas M., Price, Ric N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574534/ https://www.ncbi.nlm.nih.gov/pubmed/28850568 http://dx.doi.org/10.1371/journal.pmed.1002379

Ejemplares similares

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Early and late mortality after malaria in young children in Papua, Indonesia
por: Patriani, Dewi, et al.
Publicado: (2019)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
por: Douglas, Nicholas M, et al.
Publicado: (2014)

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2015)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
por: Dini, Saber, et al.
Publicado: (2020)

Coma Associated with Microscopy-Diagnosed Plasmodium vivax: A Prospective Study in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2011)

Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia
por: Tjitra, Emiliana, et al.
Publicado: (2008)

Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
por: Kenangalem, Enny, et al.
Publicado: (2019)

Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
por: Langford, Siobhan, et al.
Publicado: (2015)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
por: Kenangalem, Enny, et al.
Publicado: (2016)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
por: Burdam, Faustina Helena, et al.
Publicado: (2016)

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia
por: Devine, Angela, et al.
Publicado: (2018)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
por: Karyana, Muhammad, et al.
Publicado: (2016)

Therapeutic Response to Dihydroartemisinin–Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2018)

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
por: Karyana, Muhammad, et al.
Publicado: (2008)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
por: Rahmalia, Annisa, et al.
Publicado: (2023)

Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2015)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
por: Leonardo, Leo, et al.
Publicado: (2022)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2020)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
por: Oyong, Damian A., et al.
Publicado: (2018)

Case Report: Severe Plasmodium vivax Malaria after Splenectomy
por: Kambuaya, Noy Norman, et al.
Publicado: (2023)

Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia
por: Sikora, Silvester Alexandro, et al.
Publicado: (2019)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2016)

Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014–2021
por: Lestari, Trisasi, et al.
Publicado: (2022)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
por: Pava, Zuleima, et al.
Publicado: (2017)

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes
por: Wirjanata, Grennady, et al.
Publicado: (2017)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
por: Marfurt, Jutta, et al.
Publicado: (2021)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection
por: Kho, Steven, et al.
Publicado: (2016)

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study
por: Pontororing, Gysje J, et al.
Publicado: (2010)

Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms
por: Wirjanata, Grennady, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o60e9f4oai88p34itf5hmh87uo